As of Oct 25
| -0.85 / -2.06%|
The 29 analysts offering 12-month price forecasts for Fresenius Medical Care AG & Co KGaA have a median target of 50.51, with a high estimate of 58.05 and a low estimate of 35.00. The median estimate represents a +24.77% increase from the last price of 40.48.
The current consensus among 31 polled investment analysts is to Buy stock in Fresenius Medical Care AG & Co KGaA. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.